SomnoMed Limited
SOMNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.6% | 9.6% | 15.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.9% | 60.2% | 54.7% | 53.9% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1.4% | -2.5% | -3.7% | -2.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.1% | -13.4% | -9.6% | -6.1% |
| EPS Diluted | -0.016 | -0.1 | -0.097 | -0.054 |
| % Growth | 83.7% | -2.7% | -80.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |